Evidence map›Paper›PMID 24862232›Full record

ArticleAdvanced healthcare materials2014

Biphasic ferrogels for triggered drug and cell delivery.

Christine A Cezar, Stephen M Kennedy, Manav Mehta, James C Weaver, Luo Gu, Herman Vandenburgh, David J Mooney

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Review
  2. Article
  3. 4D-Printed Magnetic Responsive Bilayer Hydrogel.Nanomaterials (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Bioinspired Stimuli-Responsive Materials for Soft Actuators.Biomimetics (Basel, Switzerland) · 2024
    Review
  6. Review
  7. Review
  8. Review
  9. Magnetic Soft Materials and Robots.Chemical reviews · 2022
    Review
  10. Programmable Mechanically Active Hydrogel-Based Materials.Advanced materials (Deerfield Beach, Fla.) · 2021
    Review
  11. Magnetic systems for cancer immunotherapy.Acta pharmaceutica Sinica. B · 2021
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christine A CezarHarvard School of Engineering and Applied Sciences, Cambridge, MA, 02138, USA; Wyss Institute for Biologically Inspired Engineering, Cambridge, MA, 02138, USA.
Stephen M Kennedy
Manav Mehta
James C Weaver
Luo Gu
Herman Vandenburgh
David J Mooney

Funding

ENGINEERING SKELETAL MUSCLE WITH BIODEGRADABLE HYDROGELSR01DE013349 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOONEY, DAVID J · 2000 to 2022
$9.3M
NIDCR NIH HHS R01 DE013349
6 · The paper itself

Abstract

Ferrogels are an attractive material for many biomedical applications due to their ability to deliver a wide variety of therapeutic drugs on-demand. However, typical ferrogels have yet to be optimized for use in cell-based therapies, as they possess limited ability to harbor and release viable cells. Previously, an active porous scaffold that exhibits large deformations and enhanced biological agent release under moderate magnetic fields has been demonstrated. Unfortunately, at small device sizes optimal for implantation (e.g., 2 mm thickness), these monophasic ferrogels no longer achieve significant deformation due to a reduced body force. A new biphasic ferrogel, containing an iron oxide gradient, capable of large deformations and triggered release even at small gel dimensions, is presented in this study. Biphasic ferrogels demonstrate increased porosity, enhanced mechanical properties, and potentially increased biocompatibility due to their reduced iron oxide content. With their ability to deliver drugs and cells on-demand, it is expected that these ferrogels will have wide utility in the fields of tissue engineering and regenerative medicine.

Indexed as

AnimalsDrug CarriersDrug Delivery SystemsFemaleFerric CompoundsHydrogelsMagneticsMiceMice, Inbred C57BLPorosityRegenerative MedicineTissue EngineeringDrug CarriersFerric Compoundsferric oxideHydrogelscell therapycontrolled deliverymagnetic hydrogelsstimuli responsive

Identifiers

PMID24862232
PMCPMC4227916

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.